NCT05791786View on ClinicalTrials.gov

The Establishment of a Registry and a Biorepository of Patients With Suspected Amniotic Fluid Embolism (AFE)

RecruitingOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

July 5, 2022

Primary Completion Date

October 1, 2031

Study Completion Date

December 31, 2031

Conditions
Amniotic Fluid Embolism
Interventions
OTHER

Patient

affected individuals diagnosed with AFE

Trial Locations (1)

77030

RECRUITING

The University of Texas Health Science Center at Houston, Houston

All Listed Sponsors
collaborator

Amniotic Fluid Embolism (AFE) Foundation

UNKNOWN

lead

The University of Texas Health Science Center, Houston

OTHER